Product Program year 2024 Source: CMS Open Payments

Cellex

Device Critical Care

PDI 20705030300000

Open in the dashboard

General payments

$438,382

119 payments

Research payments

$546,190

11 payments

Through program year 2024, $438,382 in general payments and $546,190 in research payments were reported against Cellex (Critical Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2024 General $171,880 56
2024 Research $157,000 4
2023 General $116,188 59
2023 Research $255,532 5
2022 Research $78,000 1
2021 General $150,314 4
2021 Research $55,658 1

Breakdown

Who paid General payments · program years 2021–2024
  1. Mallinckrodt Hospital Products Inc. $413,622 115 payments
  2. Therakos Healthcare LLC $24,760 4 payments
Top recipients General payments · program year 2024
  1. Antonio Lombardi Endocrinology, Diabetes & Metabolism · Rahway, NJ $82,800 48% · 9 payments
  2. David Sayah Pulmonary Disease · Los Angeles, CA $12,608 7% · 3 payments
  3. Vibha Lama Pulmonary Disease · Ann Arbor, MI $11,340 7% · 3 payments
  4. Aaron Mangold Dermatology · Scottsdale, AZ $8,775 5% · 4 payments
  5. City Of Hope National Medical Ctr Teaching hospital · CA $8,500 5% · 1 payment

The top 5 of 27 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $82,800 54% · 1 practitioner
  2. Pulmonary Disease Internal Medicine $23,948 16% · 2 practitioners
  3. Dermatology $20,865 14% · 4 practitioners
  4. Gastroenterology Internal Medicine $8,060 5% · 2 practitioners
  5. Internal Medicine $4,618 3% · 3 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New Jersey $82,800 48% · 1 recipient
  2. California $27,277 16% · 8 recipients
  3. Pennsylvania $14,090 8% · 3 recipients
  4. Michigan $11,340 7% · 1 recipient
  5. Massachusetts $9,648 6% · 3 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

119 general · 11 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record